Document:

EX-10.34

 Exhibit 10.34 
 DAVITA HEALTHCARE PARTNERS INC. 
 SEVERANCE PLAN 

DaVita HealthCare Partners Inc., a Delaware corporation (the “Company”), hereby adopts the DaVita HealthCare Partners Inc.
Severance Plan (this “Plan”) for the benefit of certain Teammates of the Company and its subsidiaries. 
 This Plan is
intended to secure the continued services and ensure the continued dedication of the Teammates (as defined in Section 1(c)) by providing to such Teammates certain protections in the event of a Qualifying Termination (as defined in
Section 1(d)). 
 This Plan is intended to qualify as a Teammate welfare benefit plan as described in section 3(1) of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”). 
 1. Definitions. As used in this Plan,
the following terms shall have the respective meanings set forth below: 
 (a) “Code” means the Internal Revenue Code
of 1986, as amended. 
 (b) “Company” means DaVita HealthCare Partners Inc., a Delaware corporation. 

(c) “Teammate” means any person who is employed by the Company in a position of Vice President or Director. 

(d) “Qualifying Termination” means the involuntary termination of a Teammate’s employment by the Company under
circumstances for which the payment of severance payments and benefits under this Plan is approved by the Senior Vice President of People Services and the Assistant General Counsel – Labor of the Company; provided, however, that a
Teammate will not incur a Qualifying Termination and will not receive severance payments and benefits under this Plan if (i) the Teammate’s employment is terminated by the Company for any action which the Company, in its sole discretion,
determines is for material cause, including, but not limited to, failure to perform job responsibilities, violation of the Company’s policies and procedures, an act of fraud or dishonesty affecting or involving the Company, or a breach of a
material provision of the Teammate’s employment agreement or other similar agreement with the Company, or (ii) unless otherwise determined by the Company, a Teammate in the position of Director is terminated during the first year of the
Teammate’s employment with the Company. 
 (e) “Termination Date” with respect to a Teammate means the date on
which the Teammate incurs a “separation from service” within the meaning of Section 409A(a)(2)(A) of the Code. 

 2. Payments and Benefits Upon Qualifying Termination. If a Teammate shall incur a
Qualifying Termination, and the Teammate (or the Teammate’s executor or other legal representative in the case of the Teammate’s death or disability following such termination) executes and does not revoke a waiver and release agreement
substantially in the form of Exhibit A hereto (the “Waiver and Release”) and a noncompetition, nonsolicitation, confidentiality and cooperation agreement substantially in the form of Exhibit B hereto (the “Noncompetition
Agreement”) within 28 days following the Termination Date, the Company shall provide to the Teammate, as compensation for services rendered to the Company, and in consideration of the covenants set forth in the Waiver and Release and
Noncompetition Agreement, the payments and benefits described in this Section 2. Notwithstanding the foregoing provisions of this Section 2, if, as a result of a Teammate’s termination of employment on the Termination Date, a Teammate
is entitled to severance payments and benefits from the Company or any of its subsidiaries which are not payable pursuant to this Plan, but are payable pursuant to an employment agreement or other compensation arrangement entered into between such
Teammate and the Company or any of its subsidiaries (“Other Severance Payments and Benefits”), the payments and benefits to be received by the Teammate pursuant to this Section 2 shall be reduced by the amount of the Other Severance
Payments and Benefits, if any, received by the Teammate. 
 (a) Subject to Section 3 of this Plan, the Company shall
continue to pay to the Teammate (or the Teammate’s beneficiary or estate, as the case may be), commencing within 14 days following the date of execution of the Waiver and Release and Noncompetition Agreement, the Teammate’s base salary for
the applicable period set forth below based on the Teammate’s job classification and period of service: 
  

					
	 Job Classification
	  	 Period of Service
	  	 Salary Continuation Period

			
	Vice President	  	Less than one year	  	6 months
	Vice President	  	One year or more	  	12 months
	Director	  	Less than 3 months	  	0-3 months
	Director	  	3 to 24 months	  	3 months
	Director	  	More than 24 months	  	6 months

 The applicable salary continuation period set forth above may be extended in the sole discretion of the Chief Executive
Officer or Chief Operating Officer of the Company. 
 (b) The Company shall provide outplacement assistance to the Teammate, the
nature of which will be at the Company’s discretion, and which shall, in no event be provided after the last day of the second calendar year following the calendar year in which the termination date occurs. 

(c) The Teammate’s stock options, restricted stock units, other stock-based awards, and other long-term incentives shall be treated
in accordance with the terms of any agreements that Teammate has previously entered into with the Company concerning these benefits. 

  
 2 

 3. Plan 409A of the Code. This Plan is intended to meet the requirements of
Section 409A of the Code, and shall be interpreted and construed consistent with that intent. Notwithstanding any other provision of this Plan, to the extent that the right to any payment (including the provision of benefits) to a Teammate
hereunder provides for the “deferral of compensation” within the meaning of Section 409A(d)(1) of the Code, the payment shall be made (or provided) in accordance with the following: 

If the Teammate is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of the
Teammate’s Termination Date, then no such payment shall be made during the period beginning on the Termination Date and ending on the date that is six months following the Termination Date or, if earlier, on the date of the Teammate’s
death, if the earlier making of such payment would result in tax penalties being imposed on the Teammate under Section 409A of the Code. The amount of any payment that would otherwise be made during this period shall instead be made on the
first business day following the date that is six months following the Termination Date or, if earlier, the date of the Teammate’s death. Each payment and benefit hereunder shall constitute a “separately identified” amount within the
meaning of Treasury Regulation §1.409A-2(b)(2). 
 With respect to any payments due under Section 2(a) of this Plan as
a result of the Teammate’s Qualifying Termination or Other Severance Payments and Benefits made pursuant to the terms of this Plan, and which are subject to the Teammate’s execution and delivery of the Waiver and Release and Noncompetition
Agreement described in Section 2 hereof, in any case where the Termination Date and the Release Expiration Date fall in two separate taxable years, any payments required to be made to the Teammate which are conditioned on the timely execution
of the Waiver and Release and Noncompetition Agreement and are treated as nonqualified deferred compensation for purposes of Section 409A shall be made in the later taxable year. For purposes of this section, “Release Expiration
Date” shall mean the last day of the 28-day period following the Termination Date as described in Section 2 hereof, during which the Teammate may timely deliver an executed Waiver and Release and Noncompetition Agreement to receive
payments and benefits under this Plan. 
 4. Plan Administration; Claims Procedure. 

(a) This Plan shall be interpreted and administered by the Company, or if the Company has delegated its authority to interpret and
administer this Plan, by the person or persons appointed by the Company from time to time to interpret and administer this Plan (the “Plan Administrator”), who shall have complete authority, in his or her sole discretion subject to the
express provisions of this Plan, to make all determinations necessary or advisable for the administration of this Plan. All questions arising in connection with the interpretation of this Plan or its administration shall be submitted to and
determined by the Plan Administrator in a fair and equitable manner in accordance with the procedure for claims and appeals described in Section 4(b). 

  
 3 

 (b) Any Teammate whose employment has been terminated who believes that he or she is
entitled to receive benefits under this Plan, including benefits other than those initially determined by the Plan Administrator to be payable, may file a claim in writing with the Plan Administrator, specifying the reasons for such claim. The Plan
Administrator shall, within 90 days after receipt of such written claim (unless special circumstances require an extension of time, but in no event more than 180 days after such receipt), send a written notification to the Teammate as to the
disposition of such claim. Such notification shall be written in a manner calculated to be understood by the claimant and in the event that such claim is denied in whole or in part, shall (i) state the specific reasons for the denial,
(ii) make specific reference to the pertinent Plan provisions on which the denial is based, (iii) provide a description of any additional material or information necessary for the Teammate to perfect the claim and an explanation of why
such material or information is necessary, and (iv) set forth the procedure by which the Teammate may appeal the denial of such claim. The Teammate (or his or her duly authorized representative) may request a review of the denial of any such
claim or portion thereof by making application in writing to the Plan Administrator within 60 days after receipt of such denial. Such Teammate (or his or her duly authorized representative) may, upon written request to the Plan Administrator, review
any documents pertinent to such claim, and submit in writing issues and comments in support of such claim. Within 60 days after receipt of a written appeal (unless special circumstances require an extension of time, but in no event more than 120
days after such receipt), the Plan Administrator shall notify the Teammate of the final decision with respect to such claim. Such decision shall be written in a manner calculated to be understood by the claimant and shall state the specific reasons
for such decision and make specific references to the pertinent Plan provision on which the decision is based. 
 (c) The Plan
Administrator may from time to time delegate any of his or her duties hereunder to such person or persons as the Plan Administrator may designate. The Plan Administrator is empowered, on behalf of this Plan, to engage accountants, legal counsel and
such other persons as the Plan Administrator deems necessary or advisable for the performance of his or her duties under this Plan. The functions of any such persons engaged by the Plan Administrator shall be limited to the specified services and
duties for which they are engaged, and such persons shall have no other duties, obligations or responsibilities under this Plan. Such persons shall exercise no discretionary authority or discretionary control respecting the administration of this
Plan. All reasonable fees and expenses of such persons shall be borne by the Company. 
 5. Withholding Taxes. The
Company will withhold from all payments due under this Plan to each Teammate (or the Teammate’s beneficiary or estate) all taxes which, by applicable federal, state, local or other law, the Company is required to withhold therefrom. 

6. Amendment. The Company shall have the right, in its sole discretion, pursuant to action by the Chief Executive Officer of the
Company, to amend this Plan in any respect; provided, however, that no amendment may reduce any severance payments or benefits due hereunder with respect to a Teammate who previously incurred a Qualifying Termination and who has not
forfeited such payments and benefits pursuant to the Noncompetition 

  
 4 

 
Agreement. In the event that this Plan is determined to be a “deferred compensation plan” subject to Section 409A of the Code, the Compensation Committee of the Company’s
Board of Directors shall, as necessary, adopt such conforming amendments as are necessary to comply with Section 409A of the Code without reducing the payments and benefits due to the Teammates hereunder. 

7. Effect of Plan. Any amount payable pursuant to this Plan shall be reduced by any other amount of severance relating to salary
continuation or any other continuation of medical coverage to be received by the Teammate upon termination of employment of the Teammate under any severance plan, policy or arrangement of the Company. Subject to the foregoing and to the provisions
of Sections 2 and 8 hereof, the rights of, and benefits payable to, a Teammate pursuant to this Plan are in addition to any rights of, or benefits payable to, a Teammate under any other Teammate benefit plan or compensation program of the Company.
All rights of a Teammate under any such plan or program shall be determined in accordance with the provisions of such plan or program. 
 8. Offset; Mitigation. 
 (a) If the Company is obligated by law or contract
to pay severance pay, notice pay or other similar benefits, or if the Company is obligated by law to provide advance notice of separation (“Notice Period”), then any payments hereunder shall be reduced by the amount of any such severance
pay, notice pay or other similar benefits, as applicable, and by the amount of any severance pay, notice pay or other similar benefits received during any Notice Period. 
 (b) Any amount payable pursuant to this Plan shall also be reduced by any amount of compensation received by the Teammate from another employer (as an employee, consultant, or independent contractor)
during the applicable salary continuation period set forth in Section 2(a) hereof. Teammate may not defer compensation with his new employer or client or take any other action in an effort to avoid the dollar-for-dollar reduction required by
this Plan, and that if Teammate does take such action, the benefits under this Plan may be reduced by the Plan Administrator in its sole discretion. 
 (c) A Teammate who is entitled to receive severance payments and benefits hereunder shall be obligated to seek other employment and to take all other reasonable actions so as to mitigate the amounts
payable and the benefits to be provided to such Teammate under any of the provisions of this Plan. 
 9. Unfunded Plan.
This Plan shall not be funded. No Teammate entitled to benefits hereunder shall have any right to, or interest in, any specific assets of the Company, but a Teammate shall have only the rights of a general creditor of the Company to receive benefits
on the terms and subject to the conditions provided in this Plan. 

  
 5 

 10. Payments to Minors, Incompetents and Beneficiaries. Any benefit payable to or for
the benefit of a minor, an incompetent person or other person incapable of giving a receipt therefor shall be deemed paid when paid to such person’s guardian or to the party providing or reasonably appearing to provide for the care of such
person, and such payment shall fully discharge the Company, the Plan Administrator and all other parties with respect thereto. If a Teammate shall die while any amounts would be payable to the Teammate under this Plan had the Teammate continued to
live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Plan to such person or persons appointed in writing by the Teammate to receive such amounts or, if no person is so appointed, to the estate
of the Teammate. 
 11. Non-Assignability. None of the payments, benefits or rights of any Teammate shall be subject to
any claim of any creditor, and, in particular, to the fullest extent permitted by law, all such payments, benefits and rights shall be free from attachment, garnishment, trustee’s process or any other legal or equitable process available to any
creditor of such Teammate. Except as otherwise provided herein or by law, no right or interest of any Teammate under this Plan shall be assignable or transferable, in whole or in part, either directly or by operation of law or otherwise, including
without limitation by execution, levy, garnishment, attachment or pledge; no attempted assignment or transfer thereof shall be effective; and no right or interest of any Teammate under this Plan shall be subject to any obligation or liability of
such Teammate. 
 12. No Rights to Continued Employment. Neither the adoption of this Plan, nor any amendment hereof, nor
the creation of any fund, trust or account, nor the payment of any benefits, shall be construed as giving any Teammate the right to be retained in the service of the Company, and all Teammates shall remain subject to discharge to the same extent as
if this Plan had not been adopted. 
 13. Successors; Binding Agreement. This Plan shall inure to the benefit of and be
binding upon the beneficiaries, heirs, executors, administrators, successors and assigns of the parties, including each Teammate, present and future, and any successor to the Company or one of its subsidiaries. This Plan shall not be terminated by
any merger or consolidation of the Company whereby the Company is or is not the surviving or resulting corporation or as a result of any transfer of all or substantially all of the assets of the Company. In the event of any such merger,
consolidation or transfer of assets, the provisions of this Plan shall be binding upon the surviving or resulting corporation or the person or entity to which such assets are transferred. The Company agrees that concurrently with any merger,
consolidation or transfer of assets referred to in this Section 13, it will cause any surviving or resulting corporation or transferee unconditionally to assume all of the obligations of the Company hereunder. 

14. Headings. The headings and captions herein are provided for reference and convenience only, shall not be considered part of
this Plan and shall not be employed in the construction of this Plan. 

  
 6 

 15. Notices. Any notice or other communication required or permitted pursuant to the
terms hereof shall have been duly given when delivered or mailed by United States mail, first class, postage prepaid, addressed to the intended recipient at his, her or its last known address. 

16. Effective Date and Term. This Plan shall be effective as of the date hereof and shall end on the date on which this Plan is
terminated by the Company; provided that this Plan and the obligations of the Company hereunder shall not terminate with respect to any severance payments or benefits due hereunder with respect to a Teammate who previously incurred a Qualifying
Termination and who has not forfeited such payments and benefits pursuant to the Noncompetition Agreement until such obligations have been fully satisfied by the Company. 
 17. Employment with, and Action by, Subsidiaries. For purposes of this Plan, employment with the Company or actions taken by the Company with respect to the Teammate shall include employment with
or actions taken by any corporation or other entity in which the Company has a direct or indirect ownership interest of 50% or more of the total combined voting power of the then outstanding securities of such corporation or other entity entitled to
vote generally in the election of directors. 
 18. Governing Law; Validity. This Plan shall be governed by, and
construed and enforced in accordance with, the internal laws of the State of Delaware (without regard to principles of conflicts of laws) to the extent not preempted by ERISA or other Federal law, which shall otherwise control. If any provision of
this Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision hereof, and this Plan shall be construed and enforced as if such provision had not been included. 

IN WITNESS WHEREOF, the Company has caused this Plan to be adopted as of the 7th day of December, 2012. 

 

			
	DAVITA HEALTHCARE PARTNERS INC.
		
	By: 	 	 /s/ Laura Mildenberger

	
	Laura Mildenberger
	Chief People Officer

  
 7EX-10.60

 Exhibit 10.60 
 DaVita HealthCare Partners Inc. 
 [Performance-Based] Restricted Stock
Units Agreement 
 under the 
 DaVita Inc. 2011 Incentive Award Plan 
 and Long-Term Incentive Program

 Primary Terms 
  

			
	Grantee:	  	Sample Example
		
	Teammate Number:	  	123456
		
	Address:	  	1234 Any Street
		  	Apt. # A
		  	Any Town, US 12345
		
	Award Date:	  	
		
	[Performance Period:	  	[xxx] -year period commencing [START DATE] and ending [END DATE]]
		
	Number of Units:	  	[xxx]
		
	Plan Name:	  	2011 Incentive Award Plan
		
	Plan ID#:	  	FVA3
		
	Vesting Schedule:	  	[VESTING DATES]

 The terms set forth above, together with the terms and conditions attached, constitute one agreement.

 Note: Please mark and initial any correction to the Name, Teammate number and/or Address shown on this page before
returning a signed copy of this agreement to the Peoples Services Department. 

  
 1 

 This Restricted Stock Unit Agreement (“Agreement”) is dated as of
                    (“Award Date”) by and between DaVita HealthCare Partners Inc., a Delaware corporation (“Company”) and
Sample Example (“Grantee”) pursuant to the DaVita Inc. 2011 Incentive Award Plan (“Plan”). Capitalized terms that are used but not defined in this document shall have the meanings set forth in the Plan. 

1. Grant of RSU. The Company hereby grants to the Grantee this award (the “Award”) of restricted stock units (“Restricted Stock
Units” or “Units”) under the Plan. This Award represents the Grantee’s right to receive shares of common stock of the Company, subject to the Grantee’s fulfillment of the vesting [and performance] conditions set forth
in this Agreement. 
 2. Terms of Restricted Stock Units. The terms of the Grantee’s Award are as set forth in this Agreement and in
the Plan. The Plan is incorporated into this Agreement by reference, which means that this Agreement is limited by and subject to the terms of the Plan. In the event of a conflict between the terms of this Agreement and the terms of the Plan, the
terms of the Plan will control. 
 3. Vesting [and Performance Conditions]. 

(a) Vesting. This Award of Restricted Stock Units shall vest as follows: [VESTING DATES], [subject to the performance condition
referenced in Section [xx] below]. 
 [Subparagraphs (b) and (c) apply to Grantees subject to Code Section 162(m) as
determined by the Company] 
 (b) Performance Condition. This Award will be earned only if the performance goal
established by the Committee is achieved during the [xxx]-year period commencing on [START DATE], and ending on [END DATE] (“Performance Period”). No later than 90 days after the commencement of the Performance Period (and in no event
after 25% of the Performance Period has elapsed), the Committee shall establish, in writing, the performance goal applicable to this Award for such Performance Period and the method of calculating the number of shares subject to the Award that will
be eligible for vesting under this Award if the performance goal is attained. Such method shall be stated in terms of an objective formula or standard that precludes discretion to increase the amount of the Award that would be payable to Grantee
upon attainment of the goal. The performance goal applicable to this Award and established by the Committee for the Performance Period and the method of calculating the number of shares subject to the Award that will be eligible for vesting for such
Performance Period if the performance goal is attained may not be modified after the first 90 days (or, if less, 25%) of the Performance Period. The performance goal applicable to this Award for the Performance Period shall be based on one or more
of the Performance Criteria under the Plan. 
 (c) Certification Required. Notwithstanding any other provision in this
Agreement or any other agreement, no Shares shall become issuable to the Grantee payable under this Agreement unless and until the Committee has certified, by resolution or other appropriate action in writing, that the performance goal applicable to
this Award for the Performance Period has been accurately determined and achieved.  
 4. Conversion of Restricted Stock Units and
Stock Issuance. Upon each vesting date of the Award (each, a “Vesting Date”), one share of Common Stock will become issuable to the Grantee for each Restricted Stock Unit that vests on such Vesting Date (the “Shares”). After
the Vesting Date, the Company will issue the Shares to the Grantee, after reducing the Shares by a number of shares (if any) that are sold to satisfy the Grantee’s tax withholding obligations. No fractional shares will be issued under this
Agreement, even though such fractions may result if a portion of a share must be sold to pay the Grantee’s withholding taxes. 
 5.
Termination of Employment. The Grantee must be an employee of the Company on a Vesting Date in order to receive the Shares then vesting. Thus, Restricted Stock Units will not continue to vest if the Grantee’s employment terminates for any
reason (voluntary or involuntary), including in the event the Grantee dies, becomes disabled, retires, or changes status to that of an independent contractor. In those circumstances, the Grantee will forfeit the Grantee’s right to any
Restricted Stock Units that would otherwise vest after the date on which the Grantee’s employment is terminated. For all purposes under this Agreement and the Award, employment by the Company shall include employment by the Company or any
subsidiary thereof. 

  
 2 

 6. Right to Shares. The Grantee will not have any right to the Shares subject to the Grantee’s
Award until they are actually issued to the Grantee. 
 7. Taxes. 

(a) Generally. The Grantee is ultimately liable and responsible for all taxes owed in connection with the Award, regardless of any
action the Company or any of its subsidiaries or affiliates takes with respect to any tax withholding obligations that arise in connection with the Award. Neither the Company nor any of its subsidiaries or affiliates makes any representation or
undertaking regarding the treatment of any tax withholding in connection with the grant or vesting of the Award or the subsequent sale of Shares issuable pursuant to the Award. The Company and its subsidiaries and affiliates do not commit and are
under no obligation to structure the Award to reduce or eliminate the Grantee’s tax liability. As a condition and term of this Award, no election under 83(b) of the United States Internal Revenue Code may be made by the Grantee or any other
person with respect to all or any portion of the Award. 
 (b) Payment of Withholding Taxes. Prior to any event in
connection with the Award (e.g., vesting) that the Company determines may result in any domestic or foreign tax withholding obligation, whether national, federal, state or local, including any social tax obligation (the “Tax Withholding
Obligation”), the Grantee must arrange for the satisfaction of the minimum amount of such Tax Withholding Obligation in a manner acceptable to the Company. The Grantee may choose to satisfy the Grantee’s tax obligation in either of the
following manners: 
 (i) By Sale of Shares. Unless the Grantee chooses to satisfy the Tax
Withholding Obligation by some other means in accordance with clause (ii) below, the Grantee’s acceptance of this Award constitutes the Grantee’s instruction and authorization to the Company and any brokerage firm determined
acceptable to the Company for such purpose to withhold or sell on the Grantee’s behalf a whole number of Shares from those Shares issuable to the Grantee as the Company determines to be appropriate to generate cash proceeds sufficient to
satisfy the Tax Withholding Obligation. Such Shares will be sold on the day the tax Withholding Obligation arises (e.g., a Vesting Date) or as soon thereafter as practicable. The Grantee will be responsible for all broker’s fees and other
costs of sale, and the Grantee agrees to indemnify and hold the Company and its subsidiaries and affiliates harmless from any losses, costs, damages, or expenses relating to any such sale. To the extent the proceeds of such sale exceed the
Grantee’s Tax Withholding Obligation, the Company agrees to pay such excess in cash to the Grantee through payroll or otherwise as soon as practicable. The Grantee acknowledges that the Company or its designee is under no obligation to arrange
for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the Grantee’s Tax Withholding Obligation. Accordingly, the Grantee agrees to pay to the Company or any of its subsidiaries or
affiliates as soon as practicable, including through additional payroll withholding, any amount of Tax Withholding Obligation that is not satisfied by the sale of Shares described above. 

(ii) By Check, Wire Transfer or Other Means. At any time not less than ten (10) business days before any Tax
Withholding Obligation arises (e.g., a Vesting Date), the Grantee may notify the Company of the Grantee’s intent to make a separate cash payment to satisfy the Grantee’s Tax Withholding Obligation. If the Grantee elects to satisfy the
Grantee’s Tax Withholding Obligation in this manner, the Grantee will be asked to remit to the Company an amount that the Company determines is sufficient to satisfy the Tax Withholding Obligation within ten (10) business days after the
Vesting Date by (a) delivery of a certified check payable to the Company, attn: Dan Chandler, Manager, Stock Plan Administration, P.O Box 2076, Tacoma, Washington 98401-2076, or such other address as the Company may from time to time direct,
(b) wire transfer to such account as the Company may direct, or (c) such other means as the Company may establish or permit. If the Grantee does not remit this amount to the Company within twenty (20) business days after the Vesting
Date, the Company reserves the right to satisfy the Grantee’s Tax Withholding Obligation in the manner set out under paragraph (i) above in its sole discretion. 
 (c) Right to Retain Shares. The Company will have the right to defer the issuance of any Shares to the Grantee until the Grantee satisfies the Tax Withholding Obligation. 

  
 3 

 8. Assignment. The Grantee’s interest in this Award may not be assigned or alienated, whether
voluntarily or involuntarily. 
 9. Meaningful Reduction in Responsibilities. If there is a meaningful reduction, determined in the
Company’s sole discretion, in both the Grantee’s duties and responsibilities and the level of the Grantee’s regular cash compensation for an extended or indefinite period of time, the Company reserves the right to unilaterally revoke
some or all of the unvested portion of this Award. 
 10. Clawback Provision. Notwithstanding any other provision in this Agreement to
the contrary, the Grantee shall be subject to the written policies of the Company’s Board of Directors applicable to Company executives, including without limitation any Board policy relating to recoupment or “clawback” of
compensation arising from this Award, as they exist from time to time during the Grantee’s employment by the Company and thereafter. 

11. Amendments. Except as provided in Section 9, this Agreement and the Award may be amended only by means of a written document signed by
both the Grantee and the Company.  
 12. Change of Control of the Company. Under certain circumstances, if the Company is sold,
the Grantee’s entire Award will vest immediately. The specific rules regarding the circumstances in which full vesting would occur are contained in an exhibit to this Agreement. 
 13. Non-Competition/Non-Solicitation/Non-Disclosure 
 [Subparagraph
(a) applies to Grantees outside of California only.] (a) Non-Competition. The Grantee acknowledges and recognizes the highly competitive nature of the business of the Company and accordingly agrees that while Grantee
is an employee of the Company and for the [one year for VPs/6 months for Directors/3 months for managers] period following termination of such relationship for any reason (whether voluntary or involuntary) (the “Restricted
Period”), the Grantee shall not, as an employee, independent contractor, consultant, or in any other form, prepare to provide or provide any of the same or similar services that Grantee performed during his/her employment with (or service to)
Company for any other individual, partnership, limited liability company, corporation, independent practice association, management services organization, or any other entity (collectively, “Person”) that competes in any way with the area
of business of the Company, or any of its subsidiaries or affiliates, in which Grantee worked and/or performed services. For purposes of the above, preparing to provide any of the same or similar services includes, but is not limited to, planning
with any Person on how best to compete with Company or any of its subsidiaries or affiliates, or discussing Company’s, or any of its subsidiaries’ or affiliates’ business plans or strategies with any Person. 

The Grantee further agrees that during Restricted Period, Grantee shall not own, manage, control, operate, invest in, acquire an interest
in, or otherwise engage in, act for, or act on behalf of any Person (other than Company and its subsidiaries and affiliates) engaged in any activity that Grantee was responsible for during Grantee’s employment with Company where such activity
is similar to or competitive with the activities carried on by Company or any of its subsidiaries or affiliates. 
 The Grantee
acknowledges that during the Restricted Period, the Grantee may be exposed to confidential information and/or trade secrets relating to business areas of the Company or any of its subsidiaries or affiliates that are different from and in
addition to the areas in which Grantee primarily works for Company (the 

  
 4 

 
“Additional Protected Areas of Business”). As a result, the Grantee agrees he/she shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise act for, act
on behalf, or provide the same or similar services to, any Person that engages in the Additional Protected Areas of Business. 
 The Grantee acknowledges and agrees that the geographical limitations and duration of this covenant not to compete are reasonable. 
 To the extent that the provisions of this Section 13(a) conflict with any other agreement signed by Grantee relating to non-competition, the provisions that are most protective of the Company’s,
and any of its subsidiaries’ or affiliates’, interests shall govern. 
 (b) Non-Solicitation. Grantee
agrees that during the term of his/her employment and/or service to Company or any of its subsidiaries or affiliates and for the one-year period following the termination of his/her employment and/or service for any reason (whether voluntary or
involuntary), Grantee shall not (i) solicit any of Company’s or any of its subsidiaries’ or affiliates’ employees to work for any Person, (ii) hire any of Company’s, or any of its subsidiaries’ or affiliates’,
employees to work (as an employee or an independent contractor) for any Person, (iii) take any action that may reasonably result in any of Company’s, or any of its subsidiaries’ or affiliates’, employees going to work (as an
employee or an independent contractor) for any Person, (iv) induce any patient or customer of Company, or any of its subsidiaries or affiliates, either individually or collectively, to patronize any competing business; (v) request or
advise any patient, customer, or supplier of Company, or any of its subsidiaries or affiliates, to withdraw, curtail, or cancel such person’s business with Company, or any of its subsidiaries or affiliates; (vi) enter into any contract the
purpose or result of which would benefit Grantee if any patient or customer of Company, or any of its subsidiaries or affiliates, were to withdraw, curtail, or cancel such person’s business with Company, or any of its subsidiaries or
affiliates; (vii) solicit, induce, or encourage any physician (or former physician) affiliated with Company, or any of its subsidiaries or affiliates, or induce or encourage any other person under contract with Company, or any of its
subsidiaries or affiliates, to curtail or terminate such person’s affiliation or contractual relationship with Company, or any of its subsidiaries or affiliates; or (viii) disclose to any Person the names or addresses of any patient or
customer of Company, or any of its subsidiaries or affiliates. 
 (c) Non-Disclosure. In addition, Grantee agrees
not to disclose or use for his or her own benefit or purposes or for the benefit or purposes of any Person other than the Company and any of its subsidiaries or affiliates, any trade secrets, information, data, or other confidential information
relating to customers, development, programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, financing methods, plans, or the business and affairs of the Company or any of its subsidiaries or
affiliates (“Information”); provided, however, the foregoing shall not apply to (i) Information which is not unique to the Company or any of its subsidiaries or affiliates, or (ii) Information which is generally known to the
industry or the public other than as a result of the Grantee’s breach of this covenant, or (iii) disclosure that is required by any applicable law, rule or regulation. If Grantee receives such a request to produce Information in his or her
possession, Grantee shall provide the Company reasonable advance notice, in writing, prior to producing said Information, so as to give the Company reasonable time to object to Grantee producing said Information. Grantee also agrees that Grantee
will not become employed by or enter into service with any Person other than the Company and any of its subsidiaries or affiliates in which Grantee will be obligated to disclose or use any Information, or where such disclosure would be inevitable
because of the nature of the position. 
 (d) If, at any time (a) while the Grantee is an employee of the
Company or any of its subsidiaries or affiliates, or (b) within one (1) year after termination of Grantee’s employment with the Company, or any of its subsidiaries or affiliates, for any reason (whether voluntary or involuntary),
whichever is the latest, Grantee (i) breaches the non-competition provision of Section 13(a), (ii) breaches the non-solicitation provision of Section 13(b), (iii) breaches the non-disclosure provision of Section 13(c),
(iv) is convicted of a felony, (v) has been adjudicated by a court of competent jurisdiction of having committed an act of fraud or dishonesty resulting or intending to result directly or indirectly in personal enrichment at the expense of
the Company or any of its 

  
 5 

 
subsidiaries or affiliates, or (vi) is excluded from participating in any federal health care program, then (1) this Agreement and the Award shall terminate effective on the date on
which Grantee enters into such activity and (2) the Company may seek temporary, preliminary, and permanent injunctive relief to prevent any actual or threatened breach or continuation of any breach of this Agreement without the necessity of
proving actual damages or posting a bond or other security (which Grantee hereby agrees to) and/or an order requiring Grantee to repay the Company any value, gain or other consideration received or realized by Grantee as a result of this Award or
any Shares received pursuant to the Award. 
 14. Section 409A of the Code. This Agreement and the Award are intended to meet the
requirements of Section 409A of the Code, and shall be interpreted and construed consistent with that intent. Notwithstanding any other provisions of this Agreement, to the extent that the right to any issuance of Shares or payment to the
Grantee hereunder provides for the “deferral of compensation” within the meaning of Section 409A(d)(1) of the Code, the issuance or payment shall be made in accordance with the following: 

If the Grantee is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of the Grantee’s
“separation from service” within the meaning of Section 409A(a)(2)(A)(i) of the Code (the “Separation Date”), then no such issuance of Shares or payment shall be made during the period beginning on the Separation Date and
ending on the date that is six months following the Separation Date or, if earlier, on the date of the Grantee’s death, if the earlier making of such issuance of Shares or payment would result in tax penalties being imposed on the Grantee under
Section 409A of the Code. The amount of any issuance of Shares or payment that would otherwise be made during this period shall instead be made on the first business day following the date that is six months following the Separation Date or, if
earlier, the date of the Grantee’s death. 
 15. Execution of Award Agreement. This Agreement and the Award may be considered null
and void at the discretion of the Company if a signed copy is not returned to the Peoples Services Department no later than 120 days from the Award Date. 
 16. Compliance. It is understood and agreed upon that at all times Grantee will act in full compliance with the Company’s Code of Conduct, Policies and Procedures, JV Compliance Handbook, MDA
Compliance Handbook, Gift Policy and the credentialing process (collectively, the “Policies”).
 Grantee may not
improperly use something of value to attempt to induce or actually induce, either directly or indirectly, a patient to switch to, or continue to receive, treatment at a Company dialysis center in violation of the Policies. Inducement may
include paying a patient, providing gifts, or otherwise providing something of value to a patient to switch to, or continue to receive treatment at a Company dialysis center. Grantee also may not attempt to induce or actually induce a referral
source with something of value to obtain referrals in violation of the Policies. 
 If Grantee’s conduct, whether related
to the Award granted under this Agreement or otherwise, violates the requirements of the immediately preceding two paragraphs, then Grantee will forfeit any unvested portion of the Award granted under this Agreement and be subject to immediate
disciplinary action, up to and including termination. 
 If at any time Grantee has questions or concerns about the Compliance
provisions in this Section 16, or suspects any improper conduct related to this initiative, Grantee should immediately contact his or her supervisor or Team Quest. Grantee also may anonymously and confidentially call the Company’s
Compliance Hotline at 1-888-458-5848. 

  
 6 

 In Witness Whereof, the Company and the Grantee have executed this Agreement as of the date first
written above. 
  

					
	Grantee	 		 	Company
			
	  
	 		 	  

	Printed Name	 		 	Printed Name
			
	  
	 		 	  

	Signature	 		 	Signature
			
	  
	 		 	  

	Title	 		 	Title
			
	  
	 		 	  

	Division/Department	 		 	Division/Department

  
 7 

 EXHIBIT 
 Events Causing Full Vesting Awards 
 In the event that either
(i) in connection with a “Change of Control” (defined below), the “Acquiror” (defined below) fails to assume, convert or replace this Award, or (ii) the Grantee’s employment is terminated within the twenty-four
(24) month period following a Change of Control by the Company (or the Acquiror) other than for “Cause” (defined below) or, if applicable, by the Grantee in accordance with the termination for “Good Reason” provisions of the
Grantee’s employment agreement, if any, then, in any such case, this Award shall automatically vest and become immediately exercisable in its entirety, such vesting to be effective as of immediately prior to the effective date of the Change of
Control in the case of (i), and as of the date of termination of the Grantee’s employment in the case of (ii). 
 “Change of
Control” means: 
 (i) any transaction or series of transactions in which any person or group (within the meaning of Rule
13d-5 under the Exchange Act and Sections 13(d) and 14(d) under the Exchange Act) becomes the direct or indirect “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), by way of a stock issuance, tender offer, merger,
consolidation, other business combination or otherwise, of greater than 50% of the total voting power (on a fully diluted basis as if all convertible securities had been converted and all warrants and options had been exercised) entitled to vote in
the election of directors of the Company (including any transaction in which the Company becomes a wholly-owned or majority-owned subsidiary of another corporation), or 
 (ii) any merger or consolidation or reorganization in which the Company does not survive, or 
 (iii) any merger or consolidation in which the Company survives, but the shares of the Company’s Common Stock outstanding immediately prior to such merger or consolidation represent 50% or less of
the voting power of the Company after such merger or consolidation, or 
 (iv) any transaction in which more than 50% of the
Company’s assets are sold; 
 provided, however, that no transaction contemplated by clauses (i) through (iv) above shall
constitute a Change of Control if both (x) the person acting as the Chief Executive Officer of the Company for the six months prior to such transaction becomes the Chief Executive Officer or the Executive Chairman of the Board of Directors of
the entity that has acquired control of the Company as a result of such transaction (the “Acquiror”) immediately after such transaction and remains the Chief Executive Officer or Executive Chairman of the Board of Directors for not less
than one year following the transaction and (y) a majority of the Acquiror’s board of directors immediately after such transaction consist of persons who were directors of the Company immediately prior to such transaction. 

“Cause” means: (1) a material breach by the Grantee of those duties and responsibilities of the Grantee which do not differ in any
material respect from the duties and responsibilities of the Grantee during the ninety (90) day period immediately prior to a Change of Control (other than as a result of incapacity due to physical or mental illness) which is demonstrably
willful and deliberate on the Grantee’s part, which is committed in bad faith or without reasonable belief that such breach is in the best interests of the Company and which is not remedied in a reasonable period of time after receipt of
written notice from the Company specifying such breach; (2) willful misconduct or gross negligence which results in material harm to the Company; or (3) the conviction of the Grantee of, or a plea of nolo contendere by the Grantee
to, a felony or other crime involving fraud or dishonesty; or (4) willful violation of Company policies which results in material harm to the Company. 

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]